Foletta Mark G's Form 4 filing
Dexcom Inc (DXCM) · filed Aug 4, 2026
- Accession no.
- 0001093557-26-000145
- Filed
- Aug 4, 2026, 4:38 PM ET
- Trade date
- Jul 31-Aug 3, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $330.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foletta Mark GCIK 0001236389 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | SSaleDisposed | −2,000 | $80.00 | −$160,000 | 50,852 | Indirect | |
| Aug 3, 2026 | Common Stock | SSaleDisposed | −2,000 | $85.32 | −$170,640 | 48,852 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.